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The jaw shows a distinct phenotype in hu-
man cherubism that disappears with age.
Yoshitaka et al. now address this myste-
rious disease progression by studying
the mechanism of inflammation in a
mouse cherubism model. Absence of
TLR2/TLR4 rescues the mice from inflam-
mation.However, the inflammationoccurs
even in the absence of microorganisms.
These results suggest that both abundant
oral bacteria and active jaw remodeling
are the cause of jaw-specific lesions and
that later stabilization of jaw remodeling
might explain the age-dependent effects
of this disease.
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Cherubism is caused by mutations in SH3BP2.
Studies of cherubism mice showed that tumor ne-
crosis factor a (TNF-a)-dependent autoinflammation
is a major cause of the disorder but failed to explain
why human cherubism lesions are restricted to
jaws and regress after puberty. We demonstrate
that the inflammation in cherubism mice is MYD88
dependent and is rescued in the absence of TLR2
and TLR4. However, germ-free cherubism mice
also develop inflammation. Mutant macrophages
are hyperresponsive to PAMPs (pathogen-associ-
ated molecular patterns) and DAMPs (damage-asso-
ciated molecular patterns) that activate Toll-like
receptors (TLRs), resulting in TNF-a overproduction.
Phosphorylation of SH3BP2 at Y183 is critical for
the TNF-a production. Finally, SYK depletion in mac-
rophages prevents the inflammation. These data
suggest that the presence of a large amount of TLR
ligands, presumably oral bacteria and DAMPs dur-
ing jawbone remodeling, may cause the jaw-specific
development of human cherubism lesions. Reduced
levels of DAMPs after stabilization of jaw remodeling
may contribute to the age-dependent regression.INTRODUCTION
Autoinflammatory diseases characterized by seemingly unpro-
voked episodes of inflammation are caused by the pathologic
activation of the innate immune system and are defined by the
lack of involvement of the acquired immune system (Masters
et al., 2009; Park et al., 2012). Gene mutations responsible for1752 Cell Reports 8, 1752–1766, September 25, 2014 ª2014 The Aurare human autoinflammatory disorders have revealed key regu-
lators and underlying molecular mechanisms for innate immune
responses (Park et al., 2012). Cherubism (OMIM#118400) is
a rare genetic disorder in children characterized by disfiguring
bilateral expansion of the lower face due to bone loss in the
jaws and proliferation of inflammatory/fibrous lesions that often
regress after puberty. Heterozygous mutations in the signaling
adaptor protein SH3-domain binding protein 2 (SH3BP2) are
responsible for the disorder (Ueki et al., 2001). SH3BP2, origi-
nally discovered as a protein that binds to ABL (Ren et al.,
1993), has been found to interact with a variety of proteins
including SYK (Deckert et al., 1998), VAV (Foucault et al.,
2005), PLCg1 and PLCg2 (Deckert et al., 1998; Jevremovic
et al., 2001), and SRC (Levaot et al., 2011a) in various cells.
Phosphorylation of tyrosine residues in SH3BP2 by SYK modu-
lates downstream signaling pathways (Maeno et al., 2003).
Studies of the SH3BP2 P416R knockin (KI; equivalent to the
P418R mutation in cherubism patients) cherubism mice have
shown that homozygous mutants (Sh3bp2KI/KI) are a model for
cherubism and that they exhibit spontaneous systemic macro-
phage inflammation independently of T and B cells (Ueki et al.,
2007), indicating that cherubism is an autoinflammatory disease
(Ferguson and El-Shanti, 2007; Masters et al., 2009). Unlike in
human cherubism, lesions in Sh3bp2KI/KI mice do not regress
with age. Evidence for a key role of tumor necrosis factor a
(TNF-a) in inflammation in cherubism mice was provided by
the finding that TNF-a-deficient Sh3bp2KI/KI mice show a signif-
icant rescue from inflammation (Ueki et al., 2007). Recently, it
has been shown that SH3BP2 is a substrate of TANKYRASE
and that the cherubism mutation, which is located in the
TANKYRASE interaction site, results in reduced ADP-ribosyla-
tion of mutant SH3BP2, thereby decreasing its proteasomal
degradation and leading to TNF-a overproduction in macro-
phages (Guettler et al., 2011; Levaot et al., 2011b).
Signals from Toll-like receptors (TLRs) play a major role
in the production of inflammatory cytokines (Mogensen, 2009;thors
Takeuchi et al., 1999). TLRs primarily recognize conserved struc-
tures in microorganisms, known as pathogen-associated molec-
ular patterns (PAMPs), and are activated in the mechanisms of
host defense (Kawai and Akira, 2010). In addition, recent studies
have demonstrated that TLRs also recognize endogenous
molecules, known as damage-associated molecular patterns
(DAMPs), that are released from damaged tissues or from
dead or stressed cells, suggesting that TLRs can be self-
activated when sterile inflammation occurs (Chen and Nun˜ez,
2010; Kono and Rock, 2008; Zhang and Mosser, 2008). Myeloid
differentiation factor-88 (MYD88) is the pivotal adaptor protein
that binds to all TLRs (except for TLR3) through a Toll/inter-
leukin-1 receptor (TIR) domain, transducing TLR signals to acti-
vate downstream transcription factors such as nuclear factor-kB
(NF-kB). MYD88-deficient mice show lack of responses to
PAMPs that stimulate TLRs, indicating that the TLR-MYD88
pathway is essential for host defense (O’Neill and Bowie, 2007).
While progress has been made in understanding the function
of SH3BP2 and the pathogenesis of cherubism, it is not known
how SH3BP2 mutations cause excessive bone resorption and
soft tissue proliferation that is primarily restricted to the jaws
and why cherubism lesions regress after puberty (Berendsen
and Olsen, 2011). Here, we present data offering an explanation
for the jaw- and age-associated development of autoinflamma-
tion in cherubism by elucidating mechanisms by which mutant
SH3BP2 activates the MYD88-mediated pathway in macro-
phages in response to TLR2 and TLR4 stimulation.
RESULTS
MYD88 Ablation Rescues Sh3bp2KI/KI Cherubism Mice
from Inflammation and Bone Loss
We hypothesized that response to oral bacteria triggering
increased TLR-MYD88 pathway activation in macrophages
carrying a cherubism mutation could be the main cause for the
development of jaw-restricted cherubism lesions in humans.
TLRs recognize bacterial pathogens by binding to their cell
wall components such as peptidoglycan and lipopolysaccha-
rides (LPS) (Akira et al., 2006), downstream of which MYD88
is critically involved in transducing signals that lead to the
production of inflammatory cytokines. Indeed, MYD88-deficient
mice show unresponsiveness to bacteria (O’Neill and Bowie,
2007). To investigate the effect of TLR-mediated recognition
of bacterial components on the development of inflammation
in Sh3bp2KI/KI mice, MYD88-deficient homozygous cherubism
mice (Sh3bp2KI/KI/Myd88/) were generated. Facial swelling
with eyelid closure due to skin inflammation, which is typically
seen in Sh3bp2KI/KI mice by 6 weeks of age, was not observed
in 10-week-old Sh3bp2KI/KI/Myd88/ mice (Figure 1A). Macro-
phage-rich inflammatory infiltrates in lung, liver, and stomach
as well as in lymph nodes were almost undetectable in tissue
sections from Sh3bp2KI/KI/Myd88/ mice (Figure 1B). Micro-
computed tomography (micro-CT) images of calvarial bone
revealed a reduction in the number of bone erosion pits in
Sh3bp2KI/KI/Myd88/ mice (Figure 1C). Histomorphometric
analysis of liver tissues confirmed a significant rescue from le-
sions in Sh3bp2KI/KI/Myd88/mice (Figure 1D). Quantitativemi-
cro-CT analysis of calvarial bone showed a great reduction inCell Rebone erosion in Sh3bp2KI/KI/Myd88/mice to a level compara-
ble to that of wild-type (Sh3bp2+/+) mice (Figure 1E). Consistent
with the significant rescue of inflammatory lesions, serum TNF-a
was undetectable in the majority of double mutants (Figure 1F).
These results indicate that the MYD88-mediated signaling
pathway is critically important for the development of inflamma-
tion in Sh3bp2KI/KI mice. While SH3BP2 mutation enhanced
RANKL-induced osteoclastogenesis (Ueki et al., 2007), the
lack of MYD88 did not affect the enhanced osteoclastogenesis
(Figure S1). This suggests that the reduction of calvarial bone
erosion in Sh3bp2KI/KI/Myd88/ mice is primarily attributed to
the decreased bone resorption associated with inflammation.
MYD88-Mediated Signaling Pathway in Hematopoietic
Cells Is Critical for the Development of Inflammation in
Sh3bp2KI/KI Mice
Because hematopoietic cells are responsible for inflammation
in Sh3bp2KI/KI mice (Ueki et al., 2007), rescue of inflammation
in Sh3bp2KI/KI/Myd88/ mice suggested that the activation of
the MYD88-mediated pathway in hematopoietic cells is critical
for the development of inflammation. However, since MYD88 is
expressed in a variety of nonhematopoietic cells such as fibro-
blasts (Akira et al., 2006), we investigated whether the activation
of MYD88-mediated signals in nonhematopoietic cells contrib-
utes to the inflammation in Sh3bp2KI/KI mice by generating
bone marrow (BM) chimeric mice. Wild-type recipient mice
(Sh3bp2+/+/Myd88+/+, gray boxes in Figure 2A) transplanted
with BM cells from Sh3bp2KI/KI/Myd88/ double mutants (red
box) did not develop the typical facial swelling (Figure 2A) and
exhibited significantly reduced liver lesions and calvarial bone
erosion (Figure 2A) compared to Sh3bp2+/+/Myd88+/+ mice
transplanted with Sh3bp2KI/KI/Myd88+/+ BM cells (yellow boxes).
In contrast, Sh3bp2+/+/Myd88/ recipient mice (green box)
transplantedwithSh3bp2KI/KI/Myd88+/+ BMcells exhibited facial
swelling (Figure 2A) and developed liver inflammation and calva-
rial bone loss comparable to those in Sh3bp2+/+/Myd88+/+mice
transplanted with Sh3bp2KI/KI/Myd88+/+ BM cells (Figure 2A).
Quantitative analysis confirmed the above results (Figure 2B,
top and middle). Serum TNF-a levels were nearly undetectable
in Sh3bp2+/+/Myd88+/+ mice transplanted with Sh3bp2KI/KI/
Myd88/ cells, while they were elevated in Sh3bp2+/+/
Myd88/ mice transplanted with Sh3bp2KI/KI/Myd88+/+ cells,
which were comparable to TNF-a levels in Sh3bp2+/+/
Myd88+/+ mice transplanted with Sh3bp2KI/KI/Myd88+/+ cells
(Figure 2B, bottom). Previously, we demonstrated that the devel-
opment of macrophage-rich inflammation in Sh3bp2KI/KI mice
is independent of T and B cells but is partially dependent on
macrophage colony-stimulating factor (M-CSF) (Ueki et al.,
2007). Taken together, these results suggest that the MYD88-
mediated pathway in hematopoietic cells (primarily in macro-
phages) is responsible for the development of inflammation in
Sh3bp2KI/KI mice and that the contribution of the pathway in
nonhematopoietic cells is minimal.
TLR2 and TLR4 Play a Major Role in the Development of
Inflammation in Cherubism Mice
Significant rescue from inflammation in Sh3bp2KI/KI/Myd88/
mice is consistent with our initial hypothesis that dysregulationports 8, 1752–1766, September 25, 2014 ª2014 The Authors 1753
Figure 1. Lack of MYD88 Rescues
Sh3bp2KI/KI Mice from Inflammation
(A) Facial appearance of 10-week-old mice. Note
the open eyelids, which represent lack of facial
inflammation in the double-mutant mouse
(Sh3bp2KI/KI/Myd88/, yellow arrows) compared
to the inflamed control mouse (Sh3bp2KI/KI/
Myd88+/+, white arrows).
(B) H&E staining of tissues from 10-week-old mice
(from top: lung, liver, stomach, and lymph node).
Arrows indicate the inflammatory lesions in lung
and liver. Double-headed arrow in stomach in-
dicates the submucosal inflammatory cell infiltra-
tion rich in macrophages.
(C) Micro-CT image of the calvarial bone from
10-week-old mice.
(D) Histomorphometric analysis of liver lesions in
10-week-old mice (n = 8–16).
(E) Quantitative measurement of calvarial bone
erosion in 10-week-old mice (n = 7–11).
(F) Serum TNF-a levels in 10-week-old mice
(n = 10–21).
Horizontal bar represents average. Error bars
represent ±SD. *p < 0.05. N.D., not detected; N.S.,
not significant. See also Figure S1.of immune response to bacteria is primarily responsible for the
inflammation in cherubism. A host recognizes pathogenic and
commensal bacteria mainly through the TLR2 and TLR4 recog-
nition of bacterial components such as peptidoglycan or LPS,
respectively. To examine whether ablation of bacterial recog-
nition via TLR2 and TLR4 rescues the inflammatory phenotype,
we next knocked out both Tlr2 and Tlr4 genes in the Sh3bp2KI/KI
mice. Strikingly, Sh3bp2KI/KI/Tlr2//Tlr4lps-del/lps-del mice dis-
played rescue from facial swelling and inflammation in liver and
stomach as well as reduced bone loss in calvariae (Figure 3A,
center panels) compared to Sh3bp2KI/KI mice (Figures 1A–1C,
center panels). These results were confirmed by quantitative
measurements of liver inflammation and calvarial bone erosion
(Figure 3B). Consistent with the phenotypic rescue, serum
TNF-a levels were significantly decreased in Sh3bp2KI/KI/
Tlr2//Tlr4lps-del/lps-del triple mutants compared to Sh3bp2KI/KI1754 Cell Reports 8, 1752–1766, September 25, 2014 ª2014 The Authorsmice (Figure 3C), suggesting that ligands
for TLR2 and TLR4 are themajor inducers
of inflammation in cherubism mice.
MYD88 also serves as an adaptor pro-
tein downstream of interleukin-1 recep-
tors (IL-1Rs) (Adachi et al., 1998). This
prompted us to examine whether an
IL-1R-mediated pathway may contribute
to the inflammation in Sh3bp2KI/KI mice.
Sh3bp2KI/KI/Il1r1/ mice did exhibit
facial swelling and liver and stomach
inflammation and failed to show a reduc-
tion in calvarial bone erosion (Figure 3A,
left panels). Quantitative analysis re-
vealed that IL-1R1 deficiency resulted in
a partial reduction of liver inflammation
but no reduction of bone erosion in cal-variae (Figure 3B). Serum TNF-a levels in Sh3bp2KI/KI/Il1r1/
mice were comparable to those in Sh3bp2KI/KI mice (Figure 3C).
We further generated and analyzed quadruple-mutant mice in
which IL-1R1, TLR2, and TLR4 were ablated in the Sh3bp2KI/KI
background (Sh3bp2KI/KI/Il1r1//Tlr2//Tlr4lps-del/lps-del) (Fig-
ure 3A, right panels). These mice exhibited rescued liver inflam-
mation and calvarial bone erosion equivalent to Sh3bp2KI/KI/
Tlr2//Tlr4lps-del/lps-del triple mutants (Figure 3B). Serum TNF-a
levels in Sh3bp2KI/KI/Il1r1//Tlr2//Tlr4lps-del/lps-del quadruple
mutants were comparable to those of Sh3bp2KI/KI/Tlr2//
Tlr4lps-del/lps-del triple mutants (Figure 3C). The additional benefit
from IL-1R1 deficiency was a decrease in the percentage of
inflamed lymph nodes from 94.4% (119/126) in Sh3bp2KI/KI/
Tlr2//Tlr4lps-del/lps-del triple mutants to 67.2% (45/67) in
Sh3bp2KI/KI/Il1r1//Tlr2//Tlr4lps-del/lps-del quadruple mutants
(data not shown). Collectively, these results suggest that TLR2
Figure 2. MYD88-Mediated Pathway in
Hematopoietic Cells Is Responsible for
Inflammation in Sh3bp2KI/KI Mice
(A) Facial appearance (top), H&E staining of liver
tissue (middle), and calvarial bone micro-CT
image (bottom) of bone marrow chimeric mice
(13 weeks after transplantation). Busulfan-treated
4- to 5-week-old recipient mice (recip.) were
transplanted with bone marrow (BM) cells from 4-
week-old donor mice. Note the open eyes (yellow
arrows) and reduced liver inflammation and cal-
varial bone erosion in the Sh3bp2+/+/Myd88+/+
mouse transplanted with Sh3bp2KI/KI/Myd88/
BM cells compared to Sh3bp2+/+/Myd88/
mouse transplanted with Sh3bp2KI/KI/Myd88+/+
BM cells. White and black arrows indicate closed
eyelids due to facial skin inflammation and severe
liver lesions, respectively.
(B) Histomorphometric analysis of liver lesions
(n = 3–11), quantitative measurement of calvarial
bone erosion (n = 3–7), and serum TNF-a levels
(n = 3–11) of recipient mice 13 weeks after trans-
plantation. Horizontal bars represent average.
Error bars represent ±SD. *p < 0.05. N.D., not
detected; N.S., not significant.and TLR4 activation in macrophages is the major cause of
inflammation in Sh3bp2KI/KI mice and that the contribution of
an IL-1R-mediated pathway to the inflammation in cherubism
mice is minor compared to that of TLR2 and TLR4.
Mutant Macrophages Exhibit Increased
Responsiveness to PAMP Ligands for TLRs
Next, we examined whether bone marrow-derived M-CSF-
dependent macrophages (BMMs) from Sh3bp2KI/KI mice have
altered responsiveness to components of pathogenic microor-
ganisms that activate TLRs. TNF-a levels in culture supernatants
of Sh3bp2KI/KI BMMs stimulated with Pam3CSK4, FSL-1,
heat-killed Porphyromonas gingivalis (HKPG) and Listeria mono-Cell Reports 8, 1752–1766, Sepcytogenes (HKLM), poly(I:C), LPS, single-
stranded RNA (ssRNA), and ODN1826,
which are ligands for TLR1/2, TLR2/6,
TLR2, TLR3, TLR4, TLR7, and TLR9,
respectively, were measured and
compared to those of Sh3bp2+/+ BMMs.
Sh3bp2KI/KI BMMs produced increased
amounts of TNF-a in response not only
to TLR2 and TLR4 ligands but also
to ligands that bind to other TLRs
when compared to Sh3bp2+/+ BMM
cultures (Figure 4A–4H). Heterozygous
Sh3bp2KI/+ BMMs were susceptible to
some of the TLR ligands tested. Interest-
ingly, TNF-a production of SH3BP2-defi-
cient (Sh3bp2/) BMMs in response to
TLR ligands was equivalent to that of
Sh3bp2+/+ BMMs, indicating that lack of
SH3BP2 does not reduce the macro-
phage responsiveness to TLR ligandsin vitro and that SH3BP2 can modulate the sensitivity of TLRs
only toward the enhancement of TNF-a production in BMMs.
Further quantitative PCR analysis revealed that TLR2 or TLR4
stimulation increased TNF-a expression in Sh3bp2KI/KI BMMs
at the transcriptional level (Figure 4I).
Mutant SH3BP2 Increases TNF-a Production through
SYK-Mediated Activation of NF-kB
To identify molecular mechanisms that underlie the increased
TNF-a production in Sh3bp2KI/KI BMMs, we examined the effect
of inhibitors that selectively block signaling pathways down-
stream of TLRs. Because of the dominant role of TLR2/4 in
Sh3bp2KI/KI mice (Figures 3A–3C), we used Pam3CSK4 andtember 25, 2014 ª2014 The Authors 1755
Figure 3. Absence of TLR2 and TLR4
Rescues Inflammation in Sh3bp2KI/KI Mice
(A) Facial appearance (top), H&E staining of liver
and stomach tissues (middle), and calvarial bone
micro-CT image (bottom) of IL-1R1-deficient
Sh3bp2KI/KI, TLR2/TLR4-deficient Sh3bp2KI/KI,
and IL-1R1/TLR2/TLR4-deficient Sh3bp2KI/KI
mice at 10 weeks of age. Yellow arrows indicate
open eyelids representing rescued facial inflam-
mation. White arrows indicate closed eyelids due
to unrescued facial inflammation. Black arrows
indicate inflammatory lesions in liver and stomach.
(B) Histomorphometric analysis of liver lesions (n =
7–17) and quantitative measurement of calvarial
bone erosion (n = 7–11) in 10-week-old mice.
(C) TNF-a levels in serum of 10-week-old mice
(n = 6–22).
Horizontal bars represent average. Error bars
represent ±SD. *p < 0.05. N.D., not detected; N.S.,
not significant. Tlr4del/del = Tlr4lps-del/lps-del.LPS for further mechanistic analysis of signaling pathways.
BMMs were stimulated with Pam3CSK4 or LPS for 24 hr in the
presence or absence of chemical inhibitors, and TNF-a levels
in the culture supernatants were measured. Among inhibitors
tested (Figure S2), BMS-345541, an inhibitor of IkB kinases
(IKKs), andBAY-613606, an inhibitor of SYK, showed differences
in dose-dependent reduction of TNF-a levels in Sh3bp2KI/KI and
Sh3bp2+/+ BMM cultures (Figure 5A), suggesting that NF-kB and
SYK-mediated pathways are selectively involved in Sh3bp2KI/KI-
specific BMM activation following TLR2 and TLR4 stimulation.
Phosphorylation levels of IKKa and IKKb were constitutively
elevated in Sh3bp2KI/KI BMMs compared to Sh3bp2+/+ BMMs1756 Cell Reports 8, 1752–1766, September 25, 2014 ª2014 The Authors(Figure 5B, 0 min). In addition, mutant
cells showed sustained phosphoryla-
tion of IKKb until 240 min following
Pam3CSK4 and LPS stimulation,
while IKKb phosphorylation in wild-type
BMMs decreased by 240 min. Consistent
with increased activation of the ca-
nonical NF-kB pathway in Sh3bp2KI/KI
BMMs, levels of IkBa were decreased
throughout the culture period compared
to Sh3bp2+/+ BMMs (Figure 5B). In
agreement with the finding of Levaot
et al. (Levaot et al., 2011b), mutant
SH3BP2 protein levels were constitu-
tively increased in TLR2- and TLR4-stim-
ulated BMMs. To investigate a potential
crosstalk between SYK and IKK acti-
vation in mutant BMMs, we compared
phosphorylated IKKb levels in BMMs
stimulated with Pam3CSK4 or LPS
in the presence or absence of BAY-
613606. Increase of the phosphorylation
levels of IKKb as well as IKKa at 240 min
after stimulation were less in the pres-
ence of BAY-613606 (Figure 5C), sug-gesting that SYK activity is required for the increase in IKKb
activity in Sh3bp2KI/KIBMMs and that mutant SH3BP2 enhances
NF-kB signaling by a mechanism that involves SYK.
SYK interacts with SH3BP2 in macrophages (Figure S3)
and phosphorylates three tyrosine residues in SH3BP2 at
Y174, Y183, and Y446 (Maeno et al., 2003). Phosphorylation of
these tyrosines is critically involved in the immune response of
T cells (Qu et al., 2005) and B cells (Shukla et al., 2009). Because
overexpression of SH3BP2 in RAW264.7 cells phenocopies
the increased TNF-a production in Sh3bp2KI/KI macrophages
(Levaot et al., 2011b), we used these cells to examine to what
extent these phosphorylated tyrosines are involved in TNF-a
Figure 4. Increased Response to TLR Ligands in Sh3bp2KI/KI Macrophages
(AH) TNF-a levels in culture supernatants of BMMs stimulated with TLR ligands. BMMs from Sh3bp2KI/KI (KI/KI), Sh3bp2+/+ (+/+), and Sh3bp2/ (/) mice
were cultured in the absence of M-CSF for 4 to 6 hr, then stimulated for 24 hr with (A) Pam3CSK4, (B) FSL-1, (C) heat-killed Porphyromonas gingivalis (HKPG), (D)
heat-killed Listeria monocytogenes, (E) poly(I:C), (F) LPS, (G) ssRNA, and (H) CpG oligo DNA. Dose-dependent effects of TLR stimulation on TNF-a production
(legend continued on next page)
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production. Wild-type and various tyrosine-mutated forms of
SH3BP2 with or without the P416R cherubism mutation were
overexpressed in RAW264.7 cells, and TNF-a levels in culture
supernatants were measured. RAW264.7 cells overexpressing
the Y174/183/446F (3F) and the Y183F form of SH3BP2 showed
the most significant reduction in TNF-a production compared to
overexpression of wild-type (3Y) SH3BP2 (Figure 5D), suggest-
ing that Y183 phosphorylation is critical for SH3BP2 to induce
TNF-a overproduction in a gain-of-function manner and that
the amount of Y183-phosphorylated SH3BP2 correlates with
enhanced TNF-a production.
Next, we examined whether the Y183 phosphorylation level is
altered in Sh3bp2KI/KIBMMs stimulated with Pam3CSK4 or LPS.
Western blotting analysis using an antibody that detects Y183-
phosphorylated SH3BP2 (Figure S4) revealed that total Y183
phosphorylation is induced and increased in Sh3bp2KI/KI
BMMs after 60 min compared to Sh3bp2+/+ BMMs (Figure 5E).
When SYK activity was inhibited, these phosphorylation levels
were reduced (Figure 5F). Since phosphorylated Y183 creates
a binding site for VAV (Shukla et al., 2009) that can activate
NF-kB signaling (Costello et al., 1999; Hebeis et al., 2005), we
further investigated the phosphorylation levels of VAV. Y174
phosphorylation of VAV1 was increased in Sh3bp2KI/KI BMMs
stimulated with Pam3CSK4 compared with Sh3bp2+/+ BMMs
(Figure 5G), and the elevated phosphorylation level was sup-
pressed when SYK was inhibited (Figure 5H). Phosphorylation
of SYK at Y346, which is increased in Sh3bp2KI/KI osteoclasts
(Ueki et al., 2007), was at comparable levels in Sh3bp2KI/KI and
Sh3bp2+/+ BMMs (data not shown), suggesting that mutant
SH3BP2 does not likely affect SYK activity during the time
course observed and that increased Y183 phosphorylation in
Sh3bp2KI/KI BMMs is due to increased protein levels of mutant
SH3BP2. Collectively, these results suggest that increased
levels of mutant SH3BP2 augment NF-kB pathway activation
through SYK and that Y183 phosphorylation in SH3BP2 by
SYK leads to increased TNF-a production in Sh3bp2KI/KI
macrophages.
Germ-free Sh3bp2KI/KI Mice Develop Inflammation and
Bone Loss
Sh3bp2KI/KI macrophage activation in response to PAMPs re-
sults in elevated TNF-a production (Figures 4A–4H). Therefore,
we speculated that depletion of the microbial flora in Sh3bp2KI/KI
mice may ameliorate inflammation. To address this possibility,
we created germ-free Sh3bp2KI/KI mice (axenic Sh3bp2KI/KI
mice living in the absence of detectable microorganisms; see
Figure S5 for exclusion list) by rederiving and subsequent
crossing of Sh3bp2KI/+ mice in a sterile environment. Unexpect-
edly, germ-free Sh3bp2KI/KI mice developed substantial inflam-
mation in face, lung, liver, stomach, and lymph nodes as well
as calvarial bone loss (Figure 6A). Quantitative analysis revealed
that the severity of liver inflammation (Figure 6B) and calvarial(upper) and the critical role of MYD88 in TNF-a production in Sh3bp2KI/KI BMMs,
independent experiments.
(I) Quantitative PCR analysis of TNF-amRNA expression in BMMs stimulated with
set as 1. b-Actin was used as an endogenous control. Data are presented as me
Error bars in (A)–(H) represent ±SD. *p < 0.05 versus Sh3bp2+/+ BMMs. Tlr4del/de
1758 Cell Reports 8, 1752–1766, September 25, 2014 ª2014 The Aubone loss (Figure 6C) are even greater in germ-free Sh3bp2KI/KI
mice than in Sh3bp2KI/KI mice under specific-pathogen-free
(SPF) conditions (see Figure S5 for exclusion list). Serum
TNF-a levels were decreased in germ-free Sh3bp2KI/KI mice
compared to SPF Sh3bp2KI/KI mice (Figure 6D) but still elevated
compared to SPF Sh3bp2+/+ mice. These data suggest that
bacterial components that stimulate TLR2 and TLR4 are not
exclusive triggers of inflammation in cherubism mice.
Because inflammation in Sh3bp2KI/KI mice is primarily TLR2/
4 dependent, this result further implies that TLR2 and TLR4
ligands derived from sources other than bacteria, such as
DAMPs, are capable of inducing inflammation by activating
MYD88-mediated signaling pathways. To test whether the
cherubism mutation also sensitizes macrophage responses
to DAMPs, Sh3bp2KI/KI BMMs were stimulated with serum
amyloid A (SAA) or hyaluronic acid, which are DAMPs that
can activate TLR2 and TLR4 (Piccinini and Midwood, 2010).
In both cases, TNF-a levels were higher in Sh3bp2KI/KI BMM
culture supernatants than in Sh3bp2+/+ BMM supernatants
(Figure 6E). Sh3bp2KI/KI BMM stimulation with biglycan
exhibited similar results (data not shown). We further found
that TNF-a-stimulated Sh3bp2KI/KI BMMs and liver tissues
from Sh3bp2KI/KI mice (with no treatment) express increased
amounts of SAA (Figures 6F and 6G). Cells that undergo pro-
grammed necrosis (necroptosis) in response to TNF-a release
DAMPs (Kaczmarek et al., 2013). This led us to examine
the effect of necroptosis in the development of inflammation
in Sh3bp2KI/KI mice. Administration of necrostatin-1 (Nec-1),
an inhibitor of necroptosis (Christofferson and Yuan, 2010), to
1-week-old neonatal Sh3bp2KI/KI mice for 7 weeks significantly
decreased liver inflammation (Figure 6H). However, serum
TNF-a levels (Figure 6I) and inflammation in facial tissues,
lung, and stomach (data not shown) were not substantially
affected, suggesting that DAMPs derived from necroptosis
are only partially responsible for inflammation in Sh3bp2KI/KI
mice in a tissue-specific manner.
SYK-Dependent Macrophage Inflammation and Bone
Loss in Cherubism Mice
Given the fact that SYK phosphorylates Y183 in SH3BP2
(Maeno et al., 2003) and this phosphorylation is important for
TNF-a production in RAW264.7 cells (Figure 5D), we next ques-
tioned whether absence of SYK in macrophages may rescue
cherubism mice from inflammation in vivo. To delete SYK in
macrophages, we used LysM-Cre mice (Clausen et al., 1999)
and generated cherubism mice in which SYK is selectively defi-
cient in macrophages (Sh3bp2KI/KI/LysM-Cre/Sykfl/fl, hereafter
referred to as Sh3bp2KI/KI/SykDM/DM). The Sh3bp2KI/KI/SykDM/DM
mice exhibited significantly reduced facial swelling and lung,
liver, and stomach inflammation as well as calvarial bone
loss (Figure 7A). Histomorphometric and micro-CT analysis
confirmed the significant reduction of liver lesions (Figure 7B)except poly(I:C) (lower), are presented. n = 3. Representative results from two
Pam3CSK4 or LPS. Average expression level in Sh3bp2+/+ BMMs at 0 hr was
ans ± SEM from 3 independent experiments.
l = Tlr4lps-del/lps-del.
thors
Figure 5. P416R Cherubism Mutation Increases TNF-a Production through SYK-Mediated NF-kB Activation
(A) Effect of IKK and SYK inhibitor on TNF-a production. BMMs were starved for M-CSF for 46 hr, followed by the stimulation with Pam3CSK4 or LPS for 24 hr
in the presence or absence of different concentrations of BMS-345541 or BAY-613606. *p < 0.05 (KI/KI versus +/+), n = 3. Representative results from three
independent experiments.
(B) Western blotting analysis of BMMs stimulated with Pam3CSK4 or LPS. Before stimulation BMMs were starved for serum and M-CSF for 46 hr.
(C) Effect of SYK inhibitor (1 mM) on the activation of NF-kB pathway in the BMMs at 240 min after Pam3CSK4 or LPS stimulation.
(legend continued on next page)
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and calvarial bone erosion (Figure 7C) in Sh3bp2KI/KI/SykDM/DM
mice compared to Sh3bp2KI/KI/Sykfl/fl mice. Consistent with
these results, serum TNF-a was undetectable in Sh3bp2KI/KI/
SykDM/DM mice (Figure 7D).
To examine whether SYK-deficient Sh3bp2KI/KI BMMs
exhibit reduced TNF-a production in response to TLR2 and
TLR4 activation, we cultured BMMs from Sh3bp2KI/KI/Mx1-
Cre/Sykfl/fl mice treated with poly(I:C) (hereafter referred to as
Sh3bp2KI/KI/SykD/D), which allowed us to obtain bone marrow
cells with nearly complete target gene deletion (Aliprantis
et al., 2008). The Sh3bp2KI/KI/SykD/D BMMs produced reduced
amounts of TNF-a compared to Sh3bp2KI/KI/Sykfl/fl BMMs,
which were comparable to control Sh3bp2+/+/Sykfl/fl BMMs
(Figure 7E). Western blotting analysis further revealed that
phosphorylation levels of IKKa/b and IkB were reduced and
that total IkB levels were increased in Sh3bp2KI/KI/SykD/D
BMMs compared to Sh3bp2KI/KI/Sykfl/fl BMMs (Figure 7F), sug-
gesting that activation of the NF-kB pathway in Sh3bp2KI/KI
BMMs stimulated with TLR2 and TLR4 ligands is reduced
when SYK is deficient.
Overproduction of IL-1b is associated with a number of
autoinflammatory diseases (Masters et al., 2009). Since IL-
1R1-deficient Sh3bp2KI/KI mice showed a partial reduction
in liver inflammation (Figure 3B), we hypothesized that mutant
SH3BP2 may be involved in dysregulation of IL-1b production
and that Sh3bp2KI/KI BMMs produce more IL-1b in response
to TLR stimulation. Strikingly, IL-1b production in Sh3bp2KI/KI
BMMs was increased compared to wild-type cells (Figure 7G),
indicating that IL-1b is partially involved in the development
or maintenance of inflammation in Sh3bp2KI/KI mice. This may
explain the reduction in liver lesions in Sh3bp2KI/KI/Il1r1/
mice (Figure 3B). We further examined whether mutant
SH3BP2 enhances TNF-a-induced TNF-a expression in macro-
phages. Real-time PCR analysis revealed that TNF-a-stimulated
Sh3bp2KI/KI BMMs express increased levels of TNF-a
compared to Sh3bp2+/+ and Sh3bp2/ BMMs (Figure 7H),
suggesting an autoregulatory TNF-a inflammatory circuit that
accelerates the development of cherubism lesions once inflam-
mation has been initiated. Taken together, these data provide a
basis for understanding the development of cherubism lesions
in humans who are heterozygous for mutations in SH3BP2.
After early induction of TNF-a production by M-CSF (Ueki
et al., 2007) and following TLR ligand accumulation (this study),
mutant SH3BP2 gets involved in multiple inflammatory path-
ways in macrophages, leading to sustained and irreversible
inflammation until puberty, when the TLR-MYD88 pathway be-
comes less active, which results in the regression of cherubism
lesions (Figure 7I).(D) Effect of SH3BP2 tyrosine 174, 183, and 446 residues on TNF-a overproduct
with or without substitution of the tyrosine residues (Y) with phenylalanine (F) w
SH2-domain of SH3BP2; 3Y, Y174/183/446Y (no tyrosine substitutions); 3F, Y17
(E) Western blotting analysis of BMMs stimulated with Pam3CSK4 or LPS with a
(F) Effect of BAY-613606 (1 mM) on SH3BP2 Y183 phosphorylation in BMMs at 2
(G) Y174 phosphorylation of VAV1 (pVAV1) after Pam3CSK4 stimulation.
(H) Effect of BAY-613606 (1 mM) on VAV1 Y174 phosphorylation following Pam3
VAV1.
For stimulation, 10 ng/ml of Pam3CSK4 or LPS was used. Pam3, Pam3CSK4; BM
also Figures S2–S4.
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Jaw-Specific Development of Cherubism Lesions
Significant rescue of inflammation in TLR2/TLR4-deficient
Sh3bp2KI/KI mice and increased responses to TLR ligands in
Sh3bp2KI/KI BMMs suggest that TLR2 and TLR4 stimulation
play a major role in the development of inflammation in cherub-
ism mice. TLR2 and TLR4 are primary receptors for microbial
pathogens (Akira et al., 2006), and microorganisms play impor-
tant roles in the induction and progression of immune diseases
by modulating crosstalk between the innate and adaptive im-
mune systems (Chervonsky, 2010). Jaws are located in proximity
to the oral cavity, which harbors a variety of commensal and
pathogenic microorganisms that provide ligands for TLR2 and
TLR4 (Mogensen, 2009; Wade, 2013). The large number of
pathogenic bacteria in the oral cavity includes Porphyromonas
gingivalis, which activates TLR2 and is responsible for the
common oral disease periodontitis (Burns et al., 2006; Darveau,
2010). Dental plaques containing various other microorganisms
can also activate either TLR2 or TLR4 responses (Yoshioka
et al., 2008). Therefore, it is possible that a change in microbial
load in the oral cavity in early childhood may contribute to
the jaw specificity in cherubism patients. As a result, it is
conceivable that intensive oral health care or antibiotics treat-
ment to reduce pathogenic oral microorganisms may ameliorate
or delay cherubism symptoms.
However, the fact that germ-free cherubism mice still develop
inflammation (Figures 6A–6D) indicates that DAMPs that stimu-
late TLR2- and TLR4-mediated local immune system could
also be involved in the development of human cherubism
lesions. Indeed, a variety of DAMPs can serve as ligands for
TLR2 and/or TLR4 (Chen and Nun˜ez, 2010; Piccinini and Mid-
wood, 2010; Zhang and Mosser, 2008). Jaws are exposed to
unique challenges, since they are subject to increased tissue
and bone remodeling due to tooth eruption and strain caused
by mastication. A large amount of DAMPs may be generated in
human jaw tissues during tooth eruption and the associated
damage to gingival tissues. DAMPs may also be generated as
a result of bone remodeling associated with repair of microfrac-
tures caused by the mechanical stress of mastication. Huja et al.
reported that bone turnover in the maxilla and mandible of dogs
is higher than in the femoral bone and that bone formation rate in
the dog jaw remains high during skeletal maturation, while it
decreases with age in femurs (Huja and Beck, 2008; Huja
et al., 2006). In addition, mechanical stimulation promotes the
secretion of type I collagen and matrix-degrading enzymes
from human periodontal fibroblasts (Kook et al., 2011; Lisboa
et al., 2013), suggesting that mastication contributes to DAMPsion. RAW264.7 cells overexpressing wild-type (WT) or P416R mutant SH3BP2
ere seeded. Supernatants were collected after 24 hr (n = 5). SH2, C-terminal
4/183/446F.
ntibody against Y183-phosphorylated SH3BP2 (pY183, arrowheads).
40 min after Pam3CSK4 or LPS stimulation.
CSK4 stimulation for 240 min. Numbers indicate relative ratio of pVAV1/total
S, BMS-345541; BAY, BAY-613606. Error bars represent ±SD. *p < 0.05. See
thors
Figure 6. Microorganism-Independent Inflammation in Sh3bp2KI/KI Mice and Increased Response to DAMPs in Sh3bp2KI/KI BMMs
(A) Facial appearance, H&E staining of tissues (from top: lung, liver, stomach, and lymph node), and micro-CT image of calvarial bone of 10-week-old germ-free
Sh3bp2+/+ and Sh3bp2KI/KI mice. White arrows indicate closed eyelids due to skin inflammation. Black arrows indicate inflammatory lesions. Note the devel-
opment of inflammation in Sh3bp2KI/KI mice even under germ-free conditions.
(B) Histomorphometric quantitation of liver inflammation in 10-week-old Sh3bp2KI/KI mice under SPF (n = 15) and germ-free (n = 19) conditions.
(C) Quantitative measurement of calvarial bone erosion in 10-week-old Sh3bp2KI/KI mice under SPF (n = 11) and germ-free (n = 12) conditions.
(D) Serum TNF-a levels in 10-week-old Sh3bp2KI/KI mice under SPF (n = 21) and germ-free (n = 18) conditions.
(E) TNF-a levels in culture supernatants of BMMs stimulated with serum amyloid A (SAA) (1 mg/ml, top) or hyaluronic acid (100 mg/ml, bottom).
(legend continued on next page)
Cell Reports 8, 1752–1766, September 25, 2014 ª2014 The Authors 1761
production. Taken together, these findings support the idea that
jaw tissues are great sources of DAMPs for stimulating the local
immune system through TLRs. In fact, development of active
cherubism lesions in humans usually begins at 25 years of
age (Reichenberger et al., 2012), which coincides with the devel-
opment of the secondary dentition accompanied by increased
jawbone remodeling. Therefore, it is possible that abundant gen-
eration of DAMPs in jaw tissues contributes to the jaw-specific
development of cherubism lesions. Consequently, we hypothe-
size that stimulation of TLRs as a result of abundant production
of both PAMPs and DAMPs in the jaws may be the major cause
of jaw-specific development of human cherubism lesions. Exam-
ination of inflammatory cytokine production in macrophages of
cherubism patients in response to TLR ligandswould be required
to confirm our hypothesis.
Age-Dependent Regression of Cherubism Lesions
Jaw growth and remodeling stabilize with age due to completion
of primary tooth loss and eruption of permanent teeth, suggest-
ing that production of DAMPs in the jaw that stimulate TLRs de-
creases after puberty. Therefore, we speculate that regression of
cherubism lesions in humans can, at least in part, be attributed to
the decreased release of DAMPs in the jaw. On the other hand,
the innate immune system in humans is affected by age (Koll-
mann et al., 2012; Shaw et al., 2013). Therefore, a mechanism
that regulates age-dependent innate immune response may
contribute to the age-dependent regression. We demonstrated
here that increased activation of the MYD88-mediated path-
way in macrophages plays a key role in the inflammation in
Sh3bp2KI/KI mice. In contrast, loss-of-function mutations in
MYD88 and IL-1R-associated kinase 4 (IRAK4), a protein that
interacts with MYD88 and cooperatively activates downstream
NF-kB signaling, cause a condition of primary immunodeficiency
(PID) in humans that is particularly susceptible to infection
by pyogenic bacteria. Interestingly, the clinical condition of
MYD88- and IRAK4-deficient patients improves with age (Ku
et al., 2007; von Bernuth et al., 2008). The observation that
both MYD88- and IRAK4-deficient patients are affected mostly
in the neonatal and childhood period and appear to show clinical
improvement in adolescence suggests age-dependent matura-
tion of TLR-independent innate immunity or establishment of an-
tigen-specific adaptive immunity by T and B lymphocytes to the
morbid bacteria (Mogensen, 2009; Picard et al., 2010; von Ber-
nuth et al., 2008). Because two different MYD88-associated dis-
orders, PID and cherubism, show similar dramatic improvement
of symptoms with age, MYD88-dependent immunity seems to
become redundant and less important later in life (Casanova
et al., 2011; von Bernuth et al., 2008). Therefore, we suggest
that reduced involvement of the MYD88-mediated pathway in
macrophage activation could be another potential reason for
the regression of cherubism lesions after puberty. In addition, a(F) Quantitative PCR analysis of SAA mRNA expression in BMMs stimulated with
TNF-a stimulation was set as 1. Results from three independent experiments.
(G) Quantitative PCR analysis of SAA mRNA expression in liver tissues from 3-w
(H) Histomorphometric analysis of liver inflammation in 8-week-old Sh3bp2KI/KI m
(I) TNF-a levels in serum of 8-week-old Sh3bp2KI/KI mice injected with Nec-1 (n =
SPF, specific-pathogen-free. Horizontal bars represent average. Error bars repre
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tion might modulate the process of age-dependent regression
(Masternak and Bartke, 2012).
Comparison of Cherubism Mouse Model to
Human Cherubism
The Sh3bp2 cherubism mouse model replicates many features
of cherubism (Ueki et al., 2007). However, the mode of the inher-
itance is different between humans and mice, and most studies
in the cherubism mouse model have been conducted in homo-
zygous Sh3bp2KI/KI mice where the phenotype is strongly ex-
pressed. Evolutionary changes in the precise roles of human
and mouse orthologs often cause equivalent mutations to have
different phenotypic effects in the two species (Liao and Zhang,
2008). SH3BP2 function may be more critical in humans than
in mice, and it may take longer for heterozygous cherubism
mice to develop any inflammatory phenotype. On the other
hand, our results showed that TNF-a production levels in hetero-
zygousSh3bp2KI/+ BMMs in response to PAMPs andDAMPs are
also elevated compared to Sh3bp2+/+ BMMs (Figures 4 and 6E).
Therefore, the absence of inflammatory lesions in heterozygous
Sh3bp2KI/+ mice may be due to insufficient generation of TLR
ligands under animal facility conditions. Forced chronic stimula-
tion of Sh3bp2KI/+ mice with TLR ligands or maintaining them in
a contaminated environment for extended periods of time may
induce the development of inflammatory lesions in Sh3bp2KI/+
mice.
TLR Ligands that Trigger Inflammation in
Cherubism Mice
Since overall inflammation in germ-free Sh3bp2KI/KImice is com-
parable to that in SPF Sh3bp2KI/KI mice, the effect of PAMPs on
the development of inflammation in our SPF facility is likely to
be limited. Therefore, we conclude that DAMPs, including SAA
produced by activated Sh3bp2KI/KI BMMs and liver tissues or
hyaluronic acid (Figures 6E–6G), are potential strong inducers
of inflammation in Sh3bp2KI/KI mice. Another potential DAMP
for the development of inflammation in Sh3bp2KI/KImice is bigly-
can. Biglycan-dependent cytokine production by macrophages
is completely abolished in Tlr2//Tlr4/ mice, and biglycan
null mice are resistant to LPS- or zymosan-induced sepsis due
to reduced TNF-a production (Schaefer et al., 2005). These find-
ings suggest that extracellular matrix molecules can contribute
to the induction of inflammation by binding to TLR2 and TLR4.
The actual in vivo TLR2 and TLR4 ligands and their relative con-
tributions to the inflammation in Sh3bp2KI/KI mice have not been
determined in this study, but TLR2 seemed to be involved to a
greater extent than TLR4 in reduction of serum TNF-a levels
and liver lesions (Figure S6). Investigation of DAMPs that can
provoke inflammatory responses in cherubism mice will provide
therapeutic targets for not only cherubism but also otherTNF-a (10 ng/ml). Average expression level in Sh3bp2+/+ macrophages before
eek-old Sh3bp2+/+ (n = 6) and Sh3bp2KI/KI (n = 6) mice.
ice injected with necrostatin-1 (Nec-1) (n = 6) or DMSO (n = 8).
5) or DMSO (n = 7).
sent ±SD (B, C, E, G, and H) or ±SEM (F). *p < 0.05. See also Figure S5.
thors
Figure 7. SYK Deletion in Macrophages Rescues Sh3bp2KI/KI Mice from Inflammation and Calvarial Bone Erosion
(A) Facial appearance, H&E staining of lung, liver, and stomach tissues, and micro-CT image of calvarial bone of 8-week-old Sh3bp2KI/KI/LysM-Cre ()/Sykfl/fl
and Sh3bp2KI/KI/LysM-Cre (+)/SykDM/DM mice. Yellow arrows indicate open eyelids due to the rescue of facial skin inflammation. White arrows indicate closed
eyelids due to inflamed skin. Black arrows indicate inflammatory lesions.
(B) Histomorphometric analysis of liver lesions (n = 6–7).
(C) Quantitative measurement of calvarial bone erosion (n = 6–7).
(D) Serum TNF-a levels (n = 6–7). Horizontal bar represents average.
(legend continued on next page)
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autoinflammatory diseases (Park et al., 2012) and sterile inflam-
mation (Chen and Nun˜ez, 2010). However, because Sh3bp2KI/KI/
Tlr2//Tlr4lps-del/lps-del mice still exhibit a detectable phenotype
compared to Sh3bp2KI/KI/Myd88/ mice, we cannot exclude
the possibility that ligands for TLRs other than TLR2 and TLR4
or non-TLRs that use MYD88 (Adachi et al., 1998; Sun and
Ding, 2006) contribute to the inflammation in Sh3bp2KI/KI mice.
Mutant SH3BP2 Enhances Macrophage Activation
through SYK
The effect of SYK deficiency on the reduction of TNF-a produc-
tion is more significant in Sh3bp2KI/KI BMMs than in Sh3bp2+/+
BMMs (Figure 7E). This suggests that involvement of SYK
in TNF-a production is greater in Sh3bp2KI/KI BMMs than in
Sh3bp2+/+ BMMs and that SYK is largely involved in the signaling
pathway that enhances the NF-kB pathway in cooperation with
mutant SH3BP2.
Our study demonstrates that Y183 phosphorylation in
SH3BP2 is essential for the gain of SH3BP2 function that leads
to TNF-a overproduction in macrophages (Figure 5D). The over-
all increased Y183 phosphorylation levels in Sh3bp2KI/KI BMMs
after TLR stimulation compared to Sh3bp2+/+ BMMs (Figure 5E)
is consistent with this result. However, the degree to which the
Y183 residue of SH3BP2 is phosphorylated was not increased
in RAW264.7 cells overexpressing the P416R SH3BP2 (Fig-
ure S7), suggesting that the P416Rmutation does not accelerate
the Y183 phosphorylation. Therefore, increased levels of total
Y183 phosphorylation in Sh3bp2KI/KI BMM can be attributed
to the elevated amounts of total SH3BP2 protein, even though
the ratio to total SH3BP2 protein is decreased. Since SYK phos-
phorylates the Y183 residue in SH3BP2 (Maeno et al., 2003),
reduction of Y183 phosphorylation by a SYK inhibitor could
be a potential therapeutic option for the cherubism treatment.
Indeed, SYK ablation in macrophages rescues Sh3bp2KI/KI
mice from inflammation.
Our study provides insights into a mechanism of macrophage
activation and autoinflammation via SH3BP2. We demonstrated
the important role of mutant SH3BP2 in activation of the TLR-
MYD88-NF-kB signaling axis in macrophages, resulting in
TNF-a-driven autoinflammation and the function of SH3BP2
as an adaptor that links SYK to NF-kB activation. Although
symptoms and disease processes in Sh3bp2KI/KI mice are not
completely identical to cherubism in humans, we believe that
the cherubism mice and human cherubism patients share
common pathogenetic mechanisms. The involvement of the(E) TNF-a levels in culture media of BMMs stimulated with Pam3CSK4 (left) or LP
(F) Western blotting analysis of NF-kB pathway in Pam3CSK4- or LPS-stimulate
(G) Measurement of IL-1b levels in culture supernatants from BMMs stimulated w
(H) qPCR analysis of TNF-a mRNA expression in BMMs stimulated with TNF-a (
Representative data from three independent experiments (n = 3).
(I) Schematic proposal for the pathogenesis of cherubism. Mutant SH3BP2 increa
inflammation but also to TLR ligands (this study) for development of inflammation.
in the greater TNF-a production. SYK-mediated SH3BP2 phosphorylation at Y183
more TNF-a and IL-1b in response to TNFR and TLR2/4 stimulation, respectively (
the inflammation (Yoshitaka et al., 2014). High amounts of PAMPs and DAMPs in
remodeling as well as age-dependent maturation of MYD88-independent immun
In (A)(D), 8-week-old mice were used for the histological and micro-CT compari
bars represent ±SD, *p < 0.05. N.S., not significant.
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addressing the unresolved questions of why cherubism lesions
in humans are primarily localized to the jaws andwhy they exhibit
age-dependent regression after puberty. Therapeutically, our
results suggest that SYK inhibitors may be effective in the treat-
ment of cherubism.
EXPERIMENTAL PROCEDURES
Mice
Sh3bp2KI/KI mice were reported previously (Ueki et al., 2007). Sh3bp2/
mutant mice (Chen et al., 2007) were a gift from Dr. Rottapel. Myd88/
mice (Adachi et al., 1998) were provided by Dr. Akira. Tlr2/ (004650),
Tlr4lps-del/lps-del (007227), Il1r1/ (003245), Mx1-Cre (003556), LysM-Cre
(004781), and Sykfl/fl (017309) mice were obtained from The Jackson Labora-
tory. All strains are on C57BL/6 background and were housed in an SPF envi-
ronment at the University ofMissouri-KansasCity. Germ-freeSh3bp2KI/KImice
were created by Taconic after rederivation of SPF-Sh3bp2KI/+mice and subse-
quent crossing with germ-free Sh3bp2KI/+ mice. Germ-free shipper was used
for delivery (Figure S5). Tissue and serum of germ-free mice were harvested
immediately after arrival. To obtain SYK-deficient bone marrow cells, 4- to 6-
week old Sykfl/fl/Mx1-Cre mice were injected with poly(I:C) (250 mg/body, GE
Healthcare) intraperitoneally three times with 2-day intervals. All experiments
were performed in accordance with the guidelines of the Institutional Animal
Care and Use Committee of the University of Missouri-Kansas City.
Tissue Preparation and Histomorphometric Analysis of Liver
Inflammation
Tissues were fixed in 4% paraformaldehyde/PBS or Bouin’s solution and
embedded in paraffin. Sections (6 mm) were stained with hematoxylin and
eosin (H&E). To assess the inflammation in liver tissues, total inflammatory
area in a liver image was measured as pixels with ImageJ (NIH) and divided
by the pixels of the entire tissue image to calculate the proportion of inflamma-
tory area (%). Areas of vasculature were excluded from entire tissue area. The
formula used is: Inflammatory area (%) = 1003 (total inflamed area) / [(total tis-
sue area)  (total vascular area)]. Liver images were taken with a 43 objective
lens (E800, Nikon Instruments). Results from three to five images from different
areas of each tissue section were averaged.
Micro-CT Analysis
Paraformaldehyde-fixed calvarial tissues were subjected to micro-CT (vivaCT
40, Scanco Medical) analysis. Resulting images were used to quantitate
inflammatory bone erosion in calvarial bone. 2D images were taken with a
threshold of 300 for mineralized tissue and further processed for the 3D image
reconstruction with a spatial resolution of 10 mm. 3D images (6 mm 3 6 mm)
were used to calculate the proportion of erosion area (%) of calvarial bone.
The intersection of the coronal and sagittal sutures was used as a reference
position of the square center. Total area of bone erosion including suture
area in 6 mm 3 6 mm calvarial bone images was measured as pixels with
ImageJ and divided by the total number of pixels.S (right) for 24 hr (n = 3).
d BMMs.
ith Pam3CSK4 or LPS (n = 3).
10 ng/ml). Average expression level in Sh3bp2+/+ BMMs at 0 hr was set as 1.
ses myeloid cell responses not only to M-CSF (Ueki et al., 2007) for initiation of
Mutant SH3BP2 augments NF-kB activation in cooperation with SYK, resulting
(pY183) plays a critical role in the process. Mutant macrophages also express
dotted red lines). IL-1-mediated TNF-a inflammatory loop (blue lines) stabilizes
jaws contribute to the jaw-specific cherubism phenotype. Stabilization of jaw
e system may explain the resolution of lesions after puberty in human patients.
sons. In (E)–(G), 10 ng/ml of Pam3CSK4 or LPS was used for stimulation. Error
thors
Bone Marrow-Derived M-CSF-Dependent Macrophage Cultures
Bone marrow cells were harvested from femur, tibia, and pelvic bones of 6- to
12-week-old mice. After red blood cell lysis, cells were preincubated with min-
imum essential medium amodification (a-MEM) supplemented with 10% fetal
bovine serum (FBS) for 212 hr on Petri dishes. Nonadherent cells were
collected and cultured for 45 days with a-MEM supplemented with 10%
FBS, penicillin/streptomycin, and 30 ng/ml of murine M-CSF (Peprotech) on
Petri dishes. Adherent BMMs were harvested and 4.8 3 104 cells/well were
plated in 96-well plates without M-CSF for ELISA.
Statistical Analysis
Mean value comparison between two groups was performed with Student’s
t test (two-tailed distribution, equal variance). One-way ANOVA was used to
compare means among three or more groups. If the ANOVA showed a signif-
icant difference, Tukey-Kramer test was used as a post hoc test. p < 0.05 was
considered as statistically significant.
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